NRF2 and mutant p53 separately regulate redox balance in esophageal squamous cell carcinoma through metabolic reprogramming
- 1Department of Etiology and Carcinogenesis and State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
Abstract
Background Alterations in CUL3-KEAP1-NFE2L2 (CKN) axis and p53 lead to abnormal NRF2 activation and p53 dominant-negative (p53DN) effects to perturb the redox state in esophageal squamous cell carcinoma (ESCC). The precise roles of these, especially their interplay, in these processes remain controversial and elusive.Methods We investigated the genetic alterations of the CKN axis and p53 in ESCC/SCCs and their interplays via bioinformatical analysis and immunoblots. Specific downstream target(s) of them were identified using bulk-RNA sequencing, RT-qPCR, immunofluorescence, and immunoblots in the immortalized esophageal cell, D3. The effects of redox balance in ESCC chemoprevention were performed using an NMBzA-induced rat ESCC model.Results NRF2 and p53DN (p53R246W) enhanced the antioxidant capacity. The pentose phosphate pathway and glutathione metabolism reprogramming were responsible for NRF2-related antioxidant capacity, with G6PD and SLC7A11 were critical targets. However, no direct interplay between NRF2 and p53 was detected. The EGFR-ERK-ETS1-SLC7A11 axis is potentially responsible for the antioxidant potency of p53R246W-D3 cells. Interestingly, the exogenous oxidant artesunate could suppress carcinogenesis in the rat ESCC model.Conclusions Abnormal NRF2 activation and the effects of p53DN appear to dysregulate the redox balance independently during ESCC carcinogenesis, suggesting that targeting the redox balance could be a promising and effective ESCC prevention and treatment strategy.
Related
- Construction of a five-gene prognostic model involving T cell exhaustion and metabolic reprogramming for predicting hepatocellular carcinoma risk using LASSO: insights into immune infiltration and drug sensitivity
- Combined Loss of VHL and TSC1 Drives Clear Cell Renal Cell Carcinoma with Metabolic and Redox Reprogramming that Creates an NRF2 Dependency
- CD36-Mediated Lipid Metabolic Reprogramming in Hepatocellular Carcinoma: Crosstalk With Immunity, Ferroptosis, and Therapeutic Resistance.
- Development and validation of a ferroptosis and metabolic reprogramming gene signature for risk stratification in bladder urothelial carcinoma: A retrospective multicohort study.
- Treatment patterns and prognostic factors of radiation-associated esophageal fistula in patients with esophageal squamous cell carcinoma: a retrospective cohort study
BibTeX
@article{deng2026nrf2,
title = {{NRF2 and mutant p53 separately regulate redox balance in esophageal squamous cell carcinoma through metabolic reprogramming}},
author = {Guodong Deng and Yue Liu and Wei Zheng and Lili Qiao and Lei Xu and Yanan Yang and Hui Yuan and Xiaohong Yu and Wei Jiang and Xiying Yu},
journal = {Cancer Biology \& Therapy},
year = {2026},
month = nov,
doi = {10.1080/15384047.2026.2745287},
url = {https://doi.org/10.1080/15384047.2026.2745287},
note = {CC BY},
}
RIS
TY - JOUR
TI - NRF2 and mutant p53 separately regulate redox balance in esophageal squamous cell carcinoma through metabolic reprogramming
AU - Guodong Deng
AU - Yue Liu
AU - Wei Zheng
AU - Lili Qiao
AU - Lei Xu
AU - Yanan Yang
AU - Hui Yuan
AU - Xiaohong Yu
AU - Wei Jiang
AU - Xiying Yu
PY - 2026
DA - 2026/11/06
JO - Cancer Biology & Therapy
DO - 10.1080/15384047.2026.2745287
UR - https://doi.org/10.1080/15384047.2026.2745287
AB - Background Alterations in CUL3-KEAP1-NFE2L2 (CKN) axis and p53 lead to abnormal NRF2 activation and p53 dominant-negative (p53DN) effects to perturb the redox state in esophageal squamous cell carcinoma (ESCC). The precise roles of these, especially their interplay, in these processes remain controversial and elusive.Methods We investigated the genetic alterations of the CKN axis and p53 in ESCC/SCCs and their interplays via bioinformatical analysis and immunoblots. Specific downstream target(s) of them were identified using bulk-RNA sequencing, RT-qPCR, immunofluorescence, and immunoblots in the immortalized esophageal cell, D3. The effects of redox balance in ESCC chemoprevention were performed using an NMBzA-induced rat ESCC model.Results NRF2 and p53DN (p53R246W) enhanced the antioxidant capacity. The pentose phosphate pathway and glutathione metabolism reprogramming were responsible for NRF2-related antioxidant capacity, with G6PD and SLC7A11 were critical targets. However, no direct interplay between NRF2 and p53 was detected. The EGFR-ERK-ETS1-SLC7A11 axis is potentially responsible for the antioxidant potency of p53R246W-D3 cells. Interestingly, the exogenous oxidant artesunate could suppress carcinogenesis in the rat ESCC model.Conclusions Abnormal NRF2 activation and the effects of p53DN appear to dysregulate the redox balance independently during ESCC carcinogenesis, suggesting that targeting the redox balance could be a promising and effective ESCC prevention and treatment strategy.
SN - 1555-8576
SN - 1538-4047
ER -